Qing Li to Ovarian Neoplasms
This is a "connection" page, showing publications Qing Li has written about Ovarian Neoplasms.
Connection Strength
0.666
-
Li QQ, Lee RX, Liang H, Zhong Y, Reed E. Enhancement of cisplatin-induced apoptosis by ?-elemene in resistant human ovarian cancer cells. Med Oncol. 2013 Mar; 30(1):424.
Score: 0.337
-
Wu J, Li QQ, Zhou H, Lu Y, Li JM, Ma Y, Wang L, Fu T, Gong X, Weintraub M, Wu S, Ding H. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas. Med Oncol. 2014 Jul; 31(7):14.
Score: 0.093
-
Lee RX, Li QQ, Reed E. ?-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells. Anticancer Res. 2012 Aug; 32(8):3103-13.
Score: 0.082
-
Wang Q, Li D, Zhang W, Tang B, Li QQ, Li L. Evaluation of proteomics-identified CCL18 and CXCL1 as circulating tumor markers for differential diagnosis between ovarian carcinomas and benign pelvic masses. Int J Biol Markers. 2011 Oct-Dec; 26(4):262-73.
Score: 0.077
-
Zhang W, Yang HC, Wang Q, Yang ZJ, Chen H, Wang SM, Pan ZM, Tang BJ, Li QQ, Li L. Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis. Anticancer Res. 2011 Oct; 31(10):3423-8.
Score: 0.077